13 Июль 2009 г.

MedWatch - Medtronic Paradigm Quick-Set Infusion Sets:Nationwide recall because infusion sets may not allow insulin pump to vent air pressure properly, resulting in the device delivering too much or too little insulin

MedWatch logo MedWatch - The FDA Safety Information and Adverse Event Reporting Program

Medtronic Paradigm Quick-Set Infusion Sets

Audience: Diabetes healthcare professionals, patients

Medtronic, Inc. and FDA notified healthcare professionals and patients of a recall of Quick-set infusion sets that are used with MiniMed Paradigm insulin pumps because the affected infusion sets may not allow the insulin pump to vent air pressure properly. This could potentially result in the device delivering too much or too little insulin and may lead to serious injury or death. An infusion set is a thin plastic tube used to deliver insulin from an insulin pump to a diabetes patient, and is typically replaced by the patient every three days. Affected infusion sets are reference numbers MMT-396, MMT-397, MMT-398 and MMT-399 with lot numbers starting with the number “8". Patients should discontinue using “Lot 8” Quick-set infusion sets. The lot number (for example 8XXXXXX) is clearly marked on both the product box label, and on each individual infusion set package. Customers are being asked to return any affected infusion sets to the company.

Read the complete MedWatch Safety summary, including a link to the firm press release, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm171686.htm


You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

FDA HHS

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

What's New at CBER Update

You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.

American Red Cross Control Cells 
Posted: 7/13/2009


Manage your FDA Subscriptions:

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

FDA Issues Draft Guidance for Industry on Drug Anticounterfeiting

FDA Issues Draft Guidance for Industry on Drug Anticounterfeiting
Mon, 13 Jul 2009 11:25:00 -0500

The U.S. Food and Drug Administration today issued a draft guidance on the use of inks, pigments, flavors, and other physical-chemical identifiers (PCIDs) by manufacturers to make drug products more difficult to duplicate by counterfeiters, and to make it easier to identify the genuine version of the drug.


Manage your FDA Subscriptions:

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

L A WEIGHT LOSS RECALLS LA HOT DRINKS CAFÉ AU LAIT BECAUSE OF POSSIBLE HEALTH RISK

L A WEIGHT LOSS RECALLS LA HOT DRINKS CAFÉ AU LAIT BECAUSE OF POSSIBLE HEALTH RISK
Mon, 13 Jul 2009 11:15:00 -0500

Weight Loss Services, LP of Horsham, PA is recalling 403 cases (16,120 selling units) of L A Hot Drinks Café Au Lait net weight 4.07oz, because one of the ingredients of the product has the potential to be contaminated with Salmonella. The ingredient, an instant non-fat dry milk product, was manufactured by Plainview Milk Products Cooperative of Plainview, MN. and further processed by Associated Brands LP, Medina, NY.


Manage your FDA Subscriptions:

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Medtronic Voluntarily Recalls Specific Lots of Paradigm® Quick-Set® Infusion Sets In The United States

Medtronic Voluntarily Recalls Specific Lots of Paradigm® Quick-Set® Infusion Sets In The United States
Mon, 13 Jul 2009 09:15:00 -0500

Medtronic, Inc. has initiated a recall of specific lots of Quick-set® infusion sets that are used with MiniMed Paradigm insulin pumps. An infusion set is a thin plastic tube used to deliver insulin from an insulin pump to a diabetes patient, and is typically replaced by the patient every three days.


Manage your FDA Subscriptions:

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

U.S. Food & Drug Administration (FDA) CBER's Workshops and Conferences Update

You are subscribed to CBER's Workshops and Conferences for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.

2009 CBER Foreign Regulators Seminar 
October 5 - 9, 2009


Manage your FDA Subscriptions:

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

U.S. Food & Drug Administration (FDA) CBER's Workshops and Conferences Update

You are subscribed to CBER's Workshops and Conferences for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.

2009 CBER Foreign Regulators Seminar 
Posted: 7/10/2009


Manage your FDA Subscriptions:

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420